Human immune responses to the UK human anthrax vaccine

Journal of Applied Microbiology

Volumn 87, Issue 2, 1999, Pages 306-308

  Baillie, L W J ^a   Fowler, K ^b   Turnbull, P C B ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b Centre for Applied Microbiology and Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; VACCINES;

ANTHRAX VACCINES; ANTIBODIES RESPONSE; FURTHER WORKS; HEALTHY INDIVIDUALS; IMMUNE RESPONSE; PROTECTIVE ANTIGENS; PROTECTIVE IMMUNITIES;

ANTIBODIES;

BACTERIAL VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ANTHRAX; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION;

ANTHRAX; BACTERIA (MICROORGANISMS);

EID: 0032824924     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.1999.00899.x     Document Type: Article

References (10)

1. Anon. (1996) Antibodies and their receptors. In: Immunology, ed. Roitt, I.M., Brostoff, J. & Male, D.K. 4th edn, Chap. 4. Times Mirror International Publishers, London.
2. Baillie, L.W.J., Moore, P. and Manchee, R.J. (1996) Development of a Bacillus subtilis based system for the expression of the protective antigen of Bacillus anthracis. Proceedings of the International Workshop on Anthrax, Winchester, UK, Sept. 19-21, 1995, pp. 133-135. Salisbury Medical Bulletin, No. 87, Special Supplement.
3. Darlow, H.M., Belton, F.C. and Henderson, D.W. (1956) The use of anthrax antigen to immunise man and monkey. The Lancet 11, 476-479.
4. Gu, M.I.-L.I., Leppla, S.H. and Klinman, D.M. (1999) Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17, 340-344.
5. Lindblad, E.P. (1995) Aluminium Adjuvants. In The Theory and Practical Applications of Adjuvants ed. Stewart-Tull, D.E.S. pp. 21-36. Chichester, UK: John Wiley.
6. Little, S.F., Ivins, B.E., Fellows, P.F. and Friedlander, A.M. (1997) Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infection and Immunity 65, 5171-5175.
7. McBride, B.W., Mogg, A., Telfer, J.L., Lever, M.S., Turnbull, P.C.B. and Baillie, L. (1998) Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. Vaccine 16, 810-817.
8. Parish, W.E. (1975) Some biological activities of IgG subclass antibodies after inoculation and in disease. In Allergy ed. Ganderton, M.A. & Frankland, A.W. pp. 153-175. London. Pitman Medical.
9. Rodriguez, V., Centeno, M. and Ulrich, M. (1996) The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response. Parasite Immunology 18, 341-345.
10. Sousa, A.O., Henry, S., Maroja, F.M., Lee, F.K., Brum, L., Singh, M., Laguange, P.H. and Aucouturier, P. (1998) IgG Subclass distribution of antibody response to proteins and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clinical and Experimental Immunology 111, 48-55.